0001104659-24-037934.txt : 20240322 0001104659-24-037934.hdr.sgml : 20240322 20240322170040 ACCESSION NUMBER: 0001104659-24-037934 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240320 FILED AS OF DATE: 20240322 DATE AS OF CHANGE: 20240322 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Bhatt Padmanabh P. CENTRAL INDEX KEY: 0001539215 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35518 FILM NUMBER: 24776057 MAIL ADDRESS: STREET 1: C/O SUPERNUS PHARMACEUTICALS, INC. STREET 2: 9715 KEY WEST AVENUE CITY: ROCKVILLE STATE: MD ZIP: 20850 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SUPERNUS PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001356576 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9715 KEY WEST AVENUE CITY: ROCKVILLE STATE: MD ZIP: 20850 BUSINESS PHONE: 301-838-2500 MAIL ADDRESS: STREET 1: 9715 KEY WEST AVENUE CITY: ROCKVILLE STATE: MD ZIP: 20850 FORMER COMPANY: FORMER CONFORMED NAME: SUPERNUS PHARMACEUTICALS INC DATE OF NAME CHANGE: 20060317 4 1 tm249377-2_4seq1.xml OWNERSHIP DOCUMENT X0508 4 2024-03-20 0 0001356576 SUPERNUS PHARMACEUTICALS, INC. SUPN 0001539215 Bhatt Padmanabh P. C/O SUPERNUS PHARMACEUTICALS, INC., 9715 KEY WEST AVENUE ROCKVILLE MD 20850 0 1 0 0 Sr. VP of IP, CSO 1 Common Stock 2024-03-20 4 M 0 400 25.30 A 8970 D Common Stock 2024-03-20 4 S 0 400 35.31 D 8570 D Employee Stock Option (Right to Buy) 25.30 2024-03-20 4 M 0 400 0 D 2027-02-24 Common Stock 400 27236 D Transaction made pursuant to a 10b5-1 trading plan adopted September 7, 2023. The option vested in four equal annual installments beginning on February 24, 2018. /s/ Timothy C. Dec, as attorney-in-fact 2024-03-22